{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:49:24Z","timestamp":1793303364235,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["209135"],"award-info":[{"award-number":["209135"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","award":["26041"],"award-info":[{"award-number":["26041"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HL089856"],"award-info":[{"award-number":["U01HL089856"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HL089897"],"award-info":[{"award-number":["U01HL089897"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008184","name":"COPD Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008184","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.rmed.2021.106573","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T12:55:47Z","timestamp":1628600147000},"page":"106573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Genetics plays a limited role in predicting chronic obstructive pulmonary disease treatment response and exacerbation"],"prefix":"10.1016","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8889-8377","authenticated-orcid":false,"given":"Louise","family":"Hosking","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9575-8567","authenticated-orcid":false,"given":"Astrid","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2823-1866","authenticated-orcid":false,"given":"Joshua","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6615-6249","authenticated-orcid":false,"given":"Mathias","family":"Chiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4542-0784","authenticated-orcid":false,"given":"Dana","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8235-4811","authenticated-orcid":false,"given":"Soumitra","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-4593","authenticated-orcid":false,"given":"David A.","family":"Lipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn D.","family":"Condreay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"St Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2021.106573_bib1","first-page":"21","article-title":"Exacerbations of COPD","volume":"11","author":"Pavord","year":"2016","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2021.106573_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2019.12.014","article-title":"Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life","volume":"73","author":"Hurst","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.rmed.2021.106573_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/resp.13436","article-title":"Genetic risk factors for the development of pulmonary disease identified by genome-wide association","volume":"24","author":"Hall","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2021.106573_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1164\/rccm.201808-1455SO","article-title":"Genetic advances in chronic obstructive pulmonary disease. Insights from COPDGene","volume":"200","author":"Ragland","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106573_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41588-018-0321-7","article-title":"New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries","volume":"51","author":"Shrine","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.rmed.2021.106573_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-physiol-021317-121224","article-title":"Genetics of COPD","volume":"82","author":"Silverman","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.rmed.2021.106573_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/thoraxjnl-2017-211106","article-title":"Examining genetic susceptibility in acute exacerbations of COPD","volume":"73","author":"Wan","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2021.106573_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198920","article-title":"Genetic profile and patient-reported outcomes in chronic obstructive pulmonary disease: a systematic review","volume":"13","author":"Melro","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.rmed.2021.106573_bib10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/thoraxjnl-2016-209931","article-title":"Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD","volume":"73","author":"Dicker","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2021.106573_bib11","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1164\/rccm.201002-0151OC","article-title":"Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease","volume":"182","author":"Pillai","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106573_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/17476348.2019.1601559","article-title":"Pharmacogenomics of chronic obstructive pulmonary disease","volume":"13","author":"Hersh","year":"2019","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.rmed.2021.106573_bib13","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2021.106573_bib14","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1164\/rccm.201911-2207OC","article-title":"Reduction in all-cause mortality with fluticasone furoate\/umeclidinium\/vilanterol in patients with chronic obstructive pulmonary disease","volume":"201","author":"Lipson","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106573_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1183\/13993003.02165-2015","article-title":"A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol","volume":"48","author":"Pascoe","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106573_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/15412550903499522","article-title":"Genetic epidemiology of COPD (COPDGene) study design","volume":"7","author":"Regan","year":"2010","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2021.106573_bib17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1183\/09031936.00111707","article-title":"Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)","volume":"31","author":"Vestbo","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106573_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1164\/rccm.201710-2029OC","article-title":"Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease","volume":"198","author":"Rothnie","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106573_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/ajhp\/zxz306","article-title":"Management of chronic obstructive pulmonary disease: a review focusing on exacerbations","volume":"77","author":"Bollmeier","year":"2020","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.rmed.2021.106573_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0103-2017","article-title":"Exacerbations of COPD","volume":"27","author":"Viniol","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2021.106573_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15412555.2017.1421151","article-title":"Lessons from the past: some histories of alpha-1 antitrypsin deficiency before its discovery","volume":"15","author":"Perciaccante","year":"2018","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2021.106573_bib22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.rmed.2021.106573_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrg.2016.12","article-title":"The genetics of drug efficacy: opportunities and challenges","volume":"17","author":"Nelson","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.rmed.2021.106573_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.rmed.2016.03.019","article-title":"Genetic effects on treatment response of umeclidinium\/vilanterol in chronic obstructive pulmonary disease","volume":"114","author":"Condreay","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2021.106573_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.rmed.2019.07.004","article-title":"No genetic associations with mepolizumab efficacy in COPD with peripheral blood eosinophilia","volume":"155","author":"Condreay","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2021.106573_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/15412555.2017.1320370","article-title":"Variants of the ADRB2 gene in COPD: systematic review and meta-analyses of disease risk and treatment response","volume":"14","author":"Nielsen","year":"2017","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2021.106573_bib27","doi-asserted-by":"crossref","first-page":"e793","DOI":"10.1038\/cddis.2013.329","article-title":"Elastase induced lung epithelial cell apoptosis and emphysema through placenta growth factor","volume":"4","author":"Hou","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.rmed.2021.106573_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107381","article-title":"Altered gene expression in blood and sputum in COPD frequent exacerbators in the ECLIPSE cohort","volume":"9","author":"Singh","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.rmed.2021.106573_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00100-2015","article-title":"Clinical profile of patients with adult-onset eosinophilic asthma","volume":"2","author":"de Groot","year":"2016","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmed.2021.106573_bib30","article-title":"Blood eosinophil count and exacerbation risk in patients with COPD","volume":"50","author":"Kerkhof","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106573_bib31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2147\/COPD.S152291","article-title":"Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease","volume":"13","author":"Tashkin","year":"2018","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2021.106573_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The copenhagen general population study","volume":"193","author":"Vedel-Krogh","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106573_bib33","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1164\/rccm.201703-0592ED","article-title":"Predicting corticosteroid response in chronic obstructive pulmonary disease. Blood eosinophils gain momentum","volume":"196","author":"Singh","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106573_bib34","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1182\/blood-2009-06-221630","article-title":"Mechanisms underlying neutrophil-mediated monocyte recruitment","volume":"114","author":"Soehnlein","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.rmed.2021.106573_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1756-0500-5-401","article-title":"Critical COPD respiratory illness is linked to increased transcriptomic activity of neutrophil proteases genes","volume":"5","author":"Almansa","year":"2012","journal-title":"BMC Res. Notes"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121002791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121002791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:24:57Z","timestamp":1760617497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611121002791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":34,"alternative-id":["S0954611121002791"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106573","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics plays a limited role in predicting chronic obstructive pulmonary disease treatment response and exacerbation","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 GlaxoSmithKline Plc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106573"}}